Publications by authors named "Eva Surmacz"

Claim this Profile
E
Editorial: Obesity and cancer: update on etiology, molecular biomarkers and biotargets, clinical strategies, and epidemiology.
Eva Surmacz, Valentina Guarnotta, Michaela Ruth Reagan

Front Endocrinol (Lausanne)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Adiponectin: Friend or Foe? Toward Understanding the Complexities of Adiponectin Biology and Challenges in Pharmaceutical Development.
Eva Surmacz, Tania Fiaschi

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression.
Karolina Lomperta, Katarzyna Jakubowska, Malgorzata Grudzinska, Luiza Kanczuga-Koda, Andrzej Wincewicz, Eva Surmacz

World J Gastroenterol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.
Roberta Coroniti, Rafal Farjo, Didier J Nuno, Laszlo Otvos, Laura Scolaro, Eva Surmacz

Front Mol Biosci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models.
Roberta Coroniti, Rafal Fario, Didier J Nuno, Laszlo Otvos, Laura Scolaro, Eva Surmacz

Front Mol Biosci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of adiponectin-derived peptides for inhibition of cancer cell growth and signaling.
Laszlo Otvos, Ilona Kovalszky, Julia Olah, Roberta Coroniti, Daniel Knappe, Eva Surmacz

Biopolymers· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting of obesity pathways in cancer.
Eva Surmacz, Laszlo Otvos

Horm Mol Biol Clin Investig· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of second generation peptides modulating cellular adiponectin receptor responses.
Laszlo Otvos, Daniel Knappe, Ralf Hoffmann, Ilona Kovalszky, Julia Olah, Eva Surmacz

Front Chem· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring leptin antagonism in ophthalmic cell models.
Laura Scolaro, Cristina Parrino, Roberta Coroniti, Laszlo Otvos, Eva Surmacz

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designer adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by HIV protease inhibitors.
Jennifer K Pepping, Laszlo Otvos, Eva Surmacz, Sunita Gupta, Jeffrey N Keller

J Neuroimmune Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.
Laszlo Otvos, Stefan W Vetter, Mohit Koladia, Daniel Knappe, Rico Schmidt, Eva Surmacz

Amino Acids· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin and adiponectin: emerging therapeutic targets in breast cancer.
Eva Surmacz

J Mammary Gland Biol Neoplasia· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.
Marianna Terrasi, Viviana Bazan, Stefano Caruso, Lavinia Insalaco, Valeria Amodeo, Eva Surmacz

J Cell Physiol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designer peptide antagonist of the leptin receptor with peripheral antineoplastic activity.
Serena Beccari, Ilona Kovalszky, John D Wade, Laszlo Otvos, Eva Surmacz

Peptides· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin inhibits leptin-induced growth and migration of glioblastoma cells.
Rita Ferla, Eva Haspinger, Eva Surmacz

Oncol Lett· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment.
Laszlo Otvos, Eva Haspinger, Francesca La Russa, Federica Maspero, Patrizia Graziano, Eva Surmacz

BMC Biotechnol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis.
Laszlo Otvos, Wen-Hai Shao, Anne S Vanniasinghe, Michael A Amon, Marianna Csilla Holub, Eva Surmacz

Peptides· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the leptin receptor: a potential new mode of treatment for breast cancer.
Laszlo Otvos, Eva Surmacz

Expert Rev Anticancer Ther· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation.
Laszlo Otvos, Ilona Kovalszky, Laura Scolaro, Andras Sztodola, Julia Olah, Eva Surmacz

Biopolymers· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.
Laszlo Otvos, Ilona Kovalszky, Mirko Riolfi, Rita Ferla, Julia Olah, Eva Surmacz

Eur J Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects.
Rita Ferla, Maria Bonomi, Laszlo Otvos, Eva Surmacz

BMC Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin-based therapeutics.
Laura Scolaro, Marco Cassone, Jerzy W Kolaczynski, Laszlo Otvos, Eva Surmacz

Expert Rev Endocrinol Metab· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells.
Monica Bartucci, Susanne Svensson, Lucia Ricci-Vitiani, Rosanna Dattilo, Mauro Biffoni, Eva Surmacz

Endocr Relat Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Sandra Cascio, Aleco D'Andrea, Rita Ferla, Eva Surmacz, Eliana Gulotta

J Cell Physiol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
Mariusz Koda, Luiza Kanczuga-Koda, Mariola Sulkowska, Eva Surmacz, Stanislaw Sulkowski

BMC Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis